NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Procainamide Hydrochloride | PROCAINAMIDE HYDROCHLORIDE | Hospira, Inc. | 17e47845-daad-434c-a784-6d3875b0d704 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Paclitaxel | PACLITAXEL | Hospira, Inc. | ea28753a-8631-460a-bfdc-b101eb8ac84a | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Nipent | PENTOSTATIN | Hospira, Inc. | 674e0e6d-46ed-4868-9196-04019d667716 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Hospira, Inc. | 559a0a8c-a8fe-40a5-b196-21f9308780ab | 2026-07-01 | Warnings, Adverse reactions | Hospira, Inc. |
| CHROMIUM | CHROMIC CHLORIDE | Hospira, Inc. | b4d01ebb-a36e-44b7-028c-43c0ab2d13b4 | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Chromium | CHROMIC CHLORIDE | Hospira, Inc. | da207ca8-7836-4c66-92fe-36cc89baf773 | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Marcaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | 2026-06-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Linezolid | LINEZOLID | Hospira, Inc. | c401f1a8-cc37-461b-bfef-f2e156629bf8 | 2026-06-19 | Warnings, Adverse reactions | Hospira, Inc. |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 92b7ddaa-e45a-4b64-a802-bb5df8771dd6 | 2026-06-17 | Warnings, Adverse reactions | Hospira, Inc. |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 4419162d-81d4-49bd-96de-1729440bdb74 | 2026-06-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Dobutamine in Dextrose | DOBUTAMINE IN DEXTROSE | Hospira, Inc. | 9943a961-3b50-4847-8a84-d8414ce38daa | 2026-06-03 | Warnings, Adverse reactions | Hospira, Inc. |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | Hospira, Inc. |
| Sufentanil Citrate | SUFENTANIL CITRATE | Hospira, Inc. | 20293943-46ff-4345-1aa4-929b4e017a25 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Plegisol | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Hospira, Inc. | 35a174f0-f0d7-4ec7-3f81-d3d572c059cf | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| THAM | TROMETHAMINE | Hospira, Inc. | 4af52118-c12b-4ad5-30bb-959848357e8a | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | 8535cc84-ad4a-4d67-8480-fb5a2e3406f8 | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| DOBUTAMINE | DOBUTAMINE | Hospira, Inc. | 89becb0c-da60-4f43-0a98-29ff7a9eca58 | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| TPN Electrolytes | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | Hospira, Inc. | c00817bc-7b62-4abe-0280-e7930eda3f94 | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.